SYNTHESIS AND ANTI-FOLATE ACTIVITY OF 8,10-DIDEAZAMINOPTERIN

被引：12
|
作者：
DEGRAW, JI
KELLY, LF
KISLIUK, RL
GAUMONT, Y
SIROTNAK, FM
机构：
[1] TUFTS UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02111
[2] SLOAN KETTERING CANC CTR,DEPT MOLEC THERAPEUT,NEW YORK,NY 10021
来源：
JOURNAL OF HETEROCYCLIC CHEMISTRY | 1982年 / 19卷 / 06期
关键词：
D O I：
10.1002/jhet.5570190674
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
引用
收藏
页码：1587 / 1588
页数：2
相关论文
共 50 条
  • [41] SYNTHESIS AND EVALUATION OF 8,10-DIDEAZATETRAHYDROFOLIC ACID AND DERIVATIVES
    DEGRAW, JI
    COLWELL, WT
    KISLIUK, RL
    GAUMONT, Y
    SIROTNAK, FM
    HETEROCYCLES, 1993, 35 (02) : 755 - 761
  • [42] Potent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK28051
    Ando, Munetoshi
    Nagata, Keiko
    Nihira, Kaito
    Suzuki, Yui
    Kanda, Yutaka
    Adachi, Maiko
    Kubota, Tsuguo
    Kameyama, Naoya
    Nakano, Mariko
    Ando, Hiroshi
    Yamano, Kazuya
    Ishii, Toshihiko
    Nakai, Ryuichiro
    Nakamura, Kazuyasu
    TRANSLATIONAL ONCOLOGY, 2017, 10 (05): : 707 - 718
  • [43] Farletuzumab, a monoclonal antibody against folate receptor alpha (FRα), does not block folate or anti-folate binding or alter drug potency assessed in vitro
    Kamen, B. A.
    Smith, A. K.
    Phillips, M.
    Grasso, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] ANTI-FOLATE EFFECT OF TRIAMTERENE ON HUMAN-LEUKOCYTES AND ON A HUMAN LYMPHOMA CELL-LINE
    SCHALHORN, A
    SIEGERT, W
    SAUER, HJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (03) : 219 - 224
  • [45] Epithelial-to-mesenchymal transition (EMT) is required for resistance to anti-folate chemotherapy in lung cancer
    Liang, S.
    Marti, T. M.
    Dorn, P.
    Froment, L.
    Hall, S.
    Berezowska, S.
    Kocher, G.
    Schmid, R. A.
    Peng, R.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S63 - S63
  • [46] Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines
    Moscow, JA
    Connolly, T
    Myers, TG
    Cheng, CC
    Paull, K
    Cowan, KH
    INTERNATIONAL JOURNAL OF CANCER, 1997, 72 (01) : 184 - 190
  • [47] BIOCHEMICAL EFFECTS OF THE QUINAZOLINE ANTI-FOLATE CB3717 ON HUMAN-LYMPHOBLASTOID CELLS
    JACKSON, RC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 181 - 181
  • [48] Methotrexate Disposition, Anti-Folate Activity, and Metabolomic Profiling to Identify Molecular Markers of Disease Activity and Drug Response in the Collagen-Induced Arthritis Mouse Model
    Salamoun, Yezan M.
    Polireddy, Kishore
    Cho, Yu Kyoung
    Medcalf, Matthew R.
    Funk, Ryan S.
    METABOLITES, 2022, 12 (01)
  • [49] Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer
    Liang, S-Q
    Marti, T. M.
    Dorn, P.
    Froment, L.
    Hall, S. R. R.
    Berezowska, S.
    Kocher, G.
    Schmid, R. A.
    Peng, R-W
    CELL DEATH & DISEASE, 2015, 6 : e1824 - e1824
  • [50] Correlation of methylthioadenosine phosphorylase (MTAP) loss with response to anti-folate therapy in urothelial bladder carcinoma (UBC).
    Alhalabi, Omar
    Chen, Jianfeng
    Campbell, Matthew T.
    Tidwell, Rebecca Slack
    Han, Guangchun
    Wang, Wei-Lien
    Song, Jian H.
    Ramachandran, Sumankalai
    Lopez, Lidia
    Anh Hoang
    Siefker-Radtke, Arlene O.
    Titus, Mark Anton
    Guo, Charles
    Gallick, Gary
    Msaouel, Pavlos
    Efstathiou, Eleni
    Logothetis, Christopher
    Thai Huu Ho
    Wang, Linghua
    Gao, Jianjun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345